PMDA drug package insert
カデュエット配合錠1番
PMDA Prescription drug · ヴィアトリス製薬合同会社 · package insert Apr 14, 2026
Key facts
| Brand names | カデュエット配合錠1番, カデュエット配合錠2番, カデュエット配合錠3番, カデュエット配合錠4番 |
|---|---|
| Nonproprietary names | アムロジピンベシル酸塩・アトルバスタチンカルシウム水和物 |
| Companies | 製造販売元／ヴィアトリス製薬合同会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性Ca拮抗薬／HMG-CoA還元酵素阻害剤 |
| Therapeutic category codes | 872190 |
| YJ codes | 2190101F1020, 2190102F1025, 2190103F1020, 2190104F1024 |
| Approval numbers | 22100AMX01825, 22100AMX01826, 22100AMX01827, 22100AMX01828 |
| Package insert edition | 第5版 |
| Package insert date | Apr 14, 2026 |
| PMDA document key | 671450_2190101F1020_4 |
| PMDA company code | 671450 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: